BNP Paribas Financial Markets Grows Position in STERIS plc $STE

BNP Paribas Financial Markets raised its position in shares of STERIS plc (NYSE:STE) by 13.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 175,486 shares of the medical equipment provider’s stock after purchasing an additional 20,391 shares during the quarter. BNP Paribas Financial Markets’ holdings in STERIS were worth $44,489,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Board of the Pension Protection Fund purchased a new position in shares of STERIS in the 4th quarter worth approximately $25,000. Harbor Investment Advisory LLC boosted its holdings in shares of STERIS by 115.4% in the 4th quarter. Harbor Investment Advisory LLC now owns 112 shares of the medical equipment provider’s stock worth $28,000 after purchasing an additional 60 shares during the period. Activest Wealth Management boosted its holdings in shares of STERIS by 423.8% in the 4th quarter. Activest Wealth Management now owns 110 shares of the medical equipment provider’s stock worth $28,000 after purchasing an additional 89 shares during the period. Geneos Wealth Management Inc. boosted its holdings in shares of STERIS by 416.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 104 shares during the period. Finally, Cornerstone Planning Group LLC boosted its holdings in shares of STERIS by 342.3% in the 4th quarter. Cornerstone Planning Group LLC now owns 115 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 89 shares during the period. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on STE. Weiss Ratings cut STERIS from a “hold (c+)” rating to a “hold (c)” rating in a report on Wednesday, May 27th. Wall Street Zen upgraded STERIS from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 16th. Piper Sandler restated an “overweight” rating and set a $270.00 price objective on shares of STERIS in a report on Thursday, May 21st. Finally, KeyCorp dropped their price objective on STERIS from $291.00 to $269.00 and set an “overweight” rating for the company in a report on Wednesday, May 13th. Three research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

STERIS Trading Up 0.3%

Shares of NYSE STE opened at $210.29 on Thursday. The company has a quick ratio of 1.54, a current ratio of 2.09 and a debt-to-equity ratio of 0.25. The business has a fifty day simple moving average of $217.68 and a two-hundred day simple moving average of $239.61. The firm has a market cap of $20.52 billion, a PE ratio of 26.52 and a beta of 0.93. STERIS plc has a twelve month low of $195.14 and a twelve month high of $269.44.

STERIS (NYSE:STE) last issued its earnings results on Monday, May 11th. The medical equipment provider reported $2.83 earnings per share for the quarter, missing analysts’ consensus estimates of $2.86 by ($0.03). The firm had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.59 billion. STERIS had a net margin of 13.18% and a return on equity of 14.15%. The company’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period last year, the firm earned $2.74 earnings per share. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. Analysts expect that STERIS plc will post 11.18 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 8th will be given a $0.63 dividend. This represents a $2.52 annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend is Monday, June 8th. STERIS’s payout ratio is presently 31.78%.

STERIS Company Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.